+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Rhabdomyosarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Rhabdomyosarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hairy Cell Leukemia (HCL) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hairy Cell Leukemia (HCL) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hepatocellular Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatocellular Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HER2-Negative Breast Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

HER2-Negative Breast Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Leiomyosarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Leiomyosarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Mantle Cell Lymphoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Mantle Cell Lymphoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Melanoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Melanoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
From
Blinatumomab - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Blinatumomab - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
From
Nexavar (Sorafenib) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Nexavar (Sorafenib) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
From
Balversa - Drug Insight, 2019 - Product Thumbnail Image

Balversa - Drug Insight, 2019

  • Report
  • July 2019
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more